Ukrainian government to increase public procurements of drugs

27 February 2025

The government of Ukraine plans to increase public procurements of drugs this year and to make them more affordable for local population despite the current tough business environment in the country and the ongoing war with Russia, reports The Pharma Letter’s local correspondent.

According to a recent report, prepared by a research company Proxima Research, the current situation in the Ukrainian pharmaceutical market remains generally stable, which is reflected by the ever-growing demand for drugs among local customers and their sales. In accordance with the report, last year sales grew by about 18% in value terms, compared to 2023. Moreover 66.2% of local citizens regularly buy drugs, which significantly exceeds the figures for previous years.

This year, according to recent statements by the Ukrainian Health Minister Viktor Lyashko, the government plans to expand procurements of drugs that will be a part of the Affordable Medicines program, which involves the allocation of about 8 billion hryvnia ($192 million) for these needs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical